2.06
price down icon0.24%   -0.005
 
loading
Schlusskurs vom Vortag:
$2.065
Offen:
$2.07
24-Stunden-Volumen:
480.17K
Relative Volume:
1.00
Marktkapitalisierung:
$103.29M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-123.57M
KGV:
-0.6776
EPS:
-3.04
Netto-Cashflow:
$-97.53M
1W Leistung:
-0.96%
1M Leistung:
-2.37%
6M Leistung:
+12.57%
1J Leistung:
+7.29%
1-Tages-Spanne:
Value
$2.06
$2.08
1-Wochen-Bereich:
Value
$2.05
$2.10
52-Wochen-Spanne:
Value
$1.34
$2.17

Hillevax Inc Stock (HLVX) Company Profile

Name
Firmenname
Hillevax Inc
Name
Telefon
(617) 213-5054
Name
Adresse
321 HARRISON AVE, SUITE 500, BOSTON
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-28
Name
Neueste SEC-Einreichungen
Name
HLVX's Discussions on Twitter

Vergleichen Sie HLVX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
HLVX
Hillevax Inc
2.06 103.26M 0 -123.57M -97.53M -3.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Hillevax Inc Stock (HLVX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-09 Herabstufung H.C. Wainwright Buy → Neutral
2024-07-09 Herabstufung Leerink Partners Outperform → Market Perform
2024-07-09 Herabstufung Stifel Buy → Hold
2024-07-08 Herabstufung Guggenheim Buy → Neutral
2024-07-08 Herabstufung JP Morgan Overweight → Neutral
2023-12-13 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Hillevax Inc Aktie (HLVX) Neueste Nachrichten

pulisher
Aug 20, 2025

What data driven models say about HilleVax Inc.’s futureJuly 2025 Rallies & Stepwise Entry/Exit Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

HilleVax Inc. stock trend outlook and recovery pathQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, HLVX, AVDX on Behalf of Shareholders - MarketScreener

Aug 20, 2025
pulisher
Aug 20, 2025

HilleVax Inc. stock trend forecastGap Up & Scalable Portfolio Growth Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How to build a custom watchlist for HilleVax Inc.July 2025 Technicals & Real-Time Stock Movement Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Using data filters to optimize entry into HilleVax Inc.2025 Market Overview & Free Real-Time Volume Trigger Notifications - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Measuring HilleVax Inc.’s beta against major indicesWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Evaluating HilleVax Inc. with trendline analysisEntry Point & Safe Entry Momentum Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

HilleVax Inc. stock prediction for this weekPortfolio Growth Summary & Daily Growth Stock Tips - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Does HilleVax Inc. show high probability of reboundWeekly Loss Report & Reliable Entry Point Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Has HilleVax Inc. formed a bullish divergenceJuly 2025 Institutional & Technical Buy Zone Confirmation - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

HILLEVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF - GlobeNewswire

Aug 19, 2025
pulisher
Aug 19, 2025

What momentum shifts mean for HilleVax Inc.Weekly Market Outlook & Low Volatility Stock Suggestions - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Using fundamentals and technicals on HilleVax Inc.Quarterly Trade Summary & Fast Entry Momentum Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can swing trading help recover from HilleVax Inc. lossesMarket Movement Recap & Fast Entry Momentum Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What MACD signals say about HilleVax Inc.2025 Sector Review & Growth Oriented Trade Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

HilleVax Inc. stock daily chart insightsPortfolio Update Summary & Daily Stock Momentum Reports - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How sentiment analysis helps forecast HilleVax Inc.Market Growth Review & Step-by-Step Trade Execution Guides - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What technical models suggest about HilleVax Inc.’s comebackEarnings Risk Report & Daily Oversold Stock Bounce Ideas - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

RSI + MACD Show Convergence for HilleVax Inc.Market Sentiment Review & Daily Price Action Insights - 선데이타임즈

Aug 18, 2025
pulisher
Aug 18, 2025

Market reaction to HilleVax Inc.’s recent newsMarket Performance Report & Advanced Technical Analysis Signals - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

HilleVax Inc. Stock Performance After Earnings: Historical InsightsNew Guidance & Smart Money Movement Alerts - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

How to integrate HilleVax Inc. into portfolio analysis tools2025 Trading Volume Trends & Fast Moving Trade Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is HilleVax Inc. stock bottoming outJuly 2025 Final Week & Verified Momentum Stock Watchlist - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Has HilleVax Inc. found a price floorJuly 2025 Final Week & Daily Profit Focused Stock Screening - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Can volume confirm reversal in HilleVax Inc.2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - Newser

Aug 17, 2025

Finanzdaten der Hillevax Inc-Aktie (HLVX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Hillevax Inc-Aktie (HLVX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
HERSHBERG ROBERT
See Remarks
Feb 11 '25
Sale
1.76
11,901
21,003
1,101,498
Maltbie Shane
Chief Financial Officer
Feb 11 '25
Sale
1.76
4,345
7,659
79,887
Maltbie Shane
Chief Financial Officer
Feb 04 '25
Sale
1.89
3,946
7,458
84,232
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Kapitalisierung:     |  Volumen (24h):